Pure Global

Longyi blood glucose test system - Taiwan Registration 63e6f84aa9c15a2221135eb828d00c52

Access comprehensive regulatory information for Longyi blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 63e6f84aa9c15a2221135eb828d00c52 and manufactured by Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory. The authorized representative in Taiwan is DRAGON PHARMACEUTICAL CO., LTD..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Taibo Technology Co., Ltd. five-stock factory, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1 Competitors
2 Recent Registrations
63e6f84aa9c15a2221135eb828d00c52
Registration Details
Taiwan FDA Registration: 63e6f84aa9c15a2221135eb828d00c52
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Longyi blood glucose test system
TW: ้พๆ˜“่ก€็ณ–ๆธฌ่ฉฆ็ณป็ตฑ
Risk Class 2
Cancelled

Registration Details

63e6f84aa9c15a2221135eb828d00c52

Company Information

Product Details

Quantitatively measure the amount of glucose in the blood.

A Clinical chemistry and clinical toxicology

A.1345 Glucose Test System

Domestic;; Contract manufacturing

Dates and Status

Jan 20, 2017

Nov 28, 2020

Jul 15, 2022

Cancellation Information

Logged out

ๆœชๅฑ•ๅปถ่€Œ้€พๆœŸ่€…

Companies Making Similar Products
Top companies providing products similar to "Longyi blood glucose test system"